Cancer continues to be a significant cause of non-traumatic pediatric mortality. Diagnosis of pediatric solid tumors is paramount to prescribing the correct treatment regimen. Recent efforts have ...

In the past decade, there have been significant advances in the three techniques classically used for liver imaging—ultrasonography, CT and MRI. In this Review, the authors highlight the ...

Fig. 1. Identification of the metastasis-associated lncRNA BREA2 in breast cancer. (A) Experimental scheme for identifying lncRNAs involved in lung metastasis of breast cancer (detailed description in ...

The triglyceride-glucose (TyG) index has emerged as a reliable surrogate marker for insulin resistance and is associated with multiple malignancies. However, its role in pancreatic cancer liver ...

Functioning NETs are characterized by the hormones they produce and/or the symptoms they cause; clinical symptoms are typically observed following metastasis to the liver.

Other Syndromes Pancreatic NETs cause various well-established syndromes. For example, gastrinomas secrete gastrin and cause Zollinger-Ellison syndrome, which is characterized by peptic ulcers ...

The liver is a frequent target for the metastasis of several tumour types. However, virtually no liver-specific adhesion molecules have been described in terms of organ-specific metastasis. This study ...

A recent study published in Engineering has shed light on the impact of alcoholic liver disease (ALD) on post-transplant hepatitis B virus (HBV) reactivation and survival outcomes in patients with ...

The hepatic MRI proton density fat fraction (MRI-PDFF) value provided by multi-echo Dixon for automated segmentation of the entire liver parenchyma was recorded. A region of interest (ROI) was placed ...

The patient ultimately died of tumor recurrence 40 months postoperatively. Case 7 received only one EP cycle before refusing further chemotherapy. Liver metastases were detected at 2 months ...

About D&D Pharmatech D&D Pharmatech is a clinical-stage biopharmaceutical company focused on developing revolutionary medicines for patients with a number of metabolic, fibrotic, and neurodegenerative ...